The Barrow Neurological Institute of Phoenix, which is part of CHW's St. Joseph's Hospital and Medical Center, is one of the nation's elite centers for neurosurgery. The Institute performs about 6,000 neurosurgical procedures each year, including 1,200 brain surgeries, and is regularly listed among the best hospitals in the nation by US. News & World Report and Becker's Hospital Review.
We're pleased to announce the development of a new research center aimed at battling the deadliest of brain cancers. Backed by a planned $8 million endowment, the Barrow Brain Tumor Research Center will create a team of surgeons and scientists to use new tools, investigate new drugs and pursue breakthroughs to prolong the lives of brain-cancer patients. The goal is ambitious since progress against brain cancer has been painfully slow. Gliomas, the term for tumors that sprout in supportive brain tissue, account for 80 percent of all malignant brain tumors. While major diseases such as breast, lung and colon cancers attract considerable funding and research, it is difficult to attract comparable funding that draws scientists into the brain-tumor field because the disease, though deadly, afflicts far fewer people.
The Barrow center will hire scientists to develop five labs that focus on different areas of brain-tumor research. Two of the labs will study the role adult stem cells play in brain-tumor development. Another will focus on developing ways to prod a person's immune system as a vaccine against brain tumors. Other labs will study epigenetics, an emerging field that studies how non-genetic factors can influence how genes change or adapt. The Barrow center's goal is to double the number of clinical trials available to patients within five years, continuing until every patient has the opportunity to participate in an investigational study.
Read more at The Arizona Republic
this reserch centre will surely be a boon to the people..we will come to know different aspects of surgery and will be beneficial to healthcare fied.
Posted by: xenastar | January 03, 2011 at 08:46 PM